80 related articles for article (PubMed ID: 4045400)
1. Cervical dilatation in the nonpregnant patient with vaginal 16-dimethyl prostaglandin E2.
Nuss RC; Baird T; Benrubi G; Thompson RJ
J Fla Med Assoc; 1985 Jun; 72(6):426-7. PubMed ID: 4045400
[No Abstract] [Full Text] [Related]
2. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
Lauersen NH; Graves ZR
J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
Friedli A; De Grandi P
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
Hald F; Kristoffersen SE; Gregersen E
Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
Sidhu MS; Kent DR
Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
[TBL] [Abstract][Full Text] [Related]
6. Study of 16,16'-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal suppository for cervical dilatation in premenopausal and postmenopausal women.
Rabe T; Willinger G; Kiesel L; Runnebaum B; Kubili F; Mösche R; Nobakht N
Adv Contracept; 1985 Mar; 1(1):91-102. PubMed ID: 3916041
[TBL] [Abstract][Full Text] [Related]
7. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative cervix dilatation in 1st trimester pregnancy interruption using 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2. A randomized double-blind study].
Brügger D; Dreher E
Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):567-9. PubMed ID: 4043711
[TBL] [Abstract][Full Text] [Related]
9. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
[TBL] [Abstract][Full Text] [Related]
10. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
Shapiro AG; Lasseter K; Cobiella A; Domenzain M
Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
[TBL] [Abstract][Full Text] [Related]
11. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
[TBL] [Abstract][Full Text] [Related]
12. Vaginal administration of gemeprost for preoperative cervical dilatation in non pregnant patients.
Martinelli P; Locci M; Guerritore T; Arpaia F; Di Meglio G; Giannitelli A; Latorre PC; Montemagno U
Clin Exp Obstet Gynecol; 1989; 16(2-3):61-4. PubMed ID: 2758667
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of meteneprost potassium (a PGE2 analogue) for cervical dilation and side effects in nonpregnant women.
Eder SE; Chatterjee M; Salvio C
Prostaglandins; 1986 Jul; 32(1):19-23. PubMed ID: 3763945
[TBL] [Abstract][Full Text] [Related]
14. Preoperative cervical dilatation by vaginal pessaries containing prostaglandin E1 analogue.
Chen JK; Elder MG
Obstet Gynecol; 1983 Sep; 62(3):339-42. PubMed ID: 6348613
[TBL] [Abstract][Full Text] [Related]
15. Preoperative dilatation of the first-trimester cervix: a comparison between Lamicel and 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester pessaries.
Welch CC; Macpherson M; Johnson IR; Nicolaides K; Filshie GM
Am J Obstet Gynecol; 1984 Jun; 149(4):400-2. PubMed ID: 6731518
[TBL] [Abstract][Full Text] [Related]
16. [Priming of the cervix with prostaglandins in the first and second trimester].
Brabec W
Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
[TBL] [Abstract][Full Text] [Related]
17. Effects of endocervical administration of prostaglandin E2 on cervical dilatation and connective tissue biosynthesis in the first trimester of pregnancy.
Norström A
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():461-4. PubMed ID: 6221632
[No Abstract] [Full Text] [Related]
18. Vaginal misoprostol for cervical priming before dilatation and curettage in postmenopausal women: a randomized controlled trial.
Bunnasathiansri S; Herabutya Y; O-Prasertsawat P
J Obstet Gynaecol Res; 2004 Jun; 30(3):221-5. PubMed ID: 15210047
[TBL] [Abstract][Full Text] [Related]
19. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. IV. Possible modalities of its use in gynecology].
Stoppelli I; Piras G; Dessole S
Minerva Ginecol; 1983 Dec; 35(12):833-4. PubMed ID: 6672685
[No Abstract] [Full Text] [Related]
20. Metabolism of 16, 16-dimethyl-prostaglandin E2 in the human female.
Steffenrud S
Biochem Med; 1980 Dec; 24(3):274-92. PubMed ID: 7283984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
